Charmacy Pharmaceutical Co (HKSE:02289) LT-Debt-to-Total-Asset : 0.01 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Charmacy Pharmaceutical Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Charmacy Pharmaceutical Co's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.01.

Charmacy Pharmaceutical Co's long-term debt to total assets ratio increased from Dec. 2022 (0.01) to Dec. 2023 (0.01). It may suggest that Charmacy Pharmaceutical Co is progressively becoming more dependent on debt to grow their business.

Charmacy Pharmaceutical Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Charmacy Pharmaceutical Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Charmacy Pharmaceutical Co LT-Debt-to-Total-Asset Chart

Charmacy Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.06

0.05

0.04

0.01

Charmacy Pharmaceutical Co Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial														0.04	0.03	0.01	0.01	0.01

Charmacy Pharmaceutical Co LT-Debt-to-Total-Asset Calculation

Charmacy Pharmaceutical Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	33.24	/	3552.218
	=	0.01

Charmacy Pharmaceutical Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )	/	Total Assets (Q: Dec. 2023 )
	=	33.24	/	3552.218
	=	0.01

Charmacy Pharmaceutical Co (HKSE:02289) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Charmacy Pharmaceutical Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Charmacy Pharmaceutical Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Charmacy Pharmaceutical Co (HKSE:02289) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Charmacy Pharmaceutical Co Ltd (HKSE:02289) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 235, Song Shan North Road, Longhu District, Guangdong Province, Shantou, CHN, 515041

Website

https://www.chmyy.com

Charmacy Pharmaceutical Co Ltd is a China-based pharmaceutical distributor. It distributes diversified pharmaceutical products to pharmaceutical distributors, retail pharmacies, hospitals, clinics, and health centers. The company's distribution network covers Southern China and surrounding areas including Fujian province. The firm offers Western medicines, Chinese patent medicines, healthcare products, Chinese medicine material and decoction pieces, medical devices, cosmetic products, and others. All the group's operations are located in China.

Charmacy Pharmaceutical Co (HKSE:02289) Headlines

No Headlines